Iress Limited

Iress closed Friday at $7.91, the end of a three-week vertical leg that carried the stock from a $6.32 swing low on July 24 to an $8.02 high on August 13 — and, on the two-year view, 40.2% off the $5.64 low that ended a long decline. The trend readings are about as forceful as this chart gets: a correctly ordered and rising moving-average stack, ADX at 45.3, a MACD golden cross from July 27 still widening, and on-balance volume in accumulation on both timeframes. The tension is the other side of the same coin. RSI at 75.5 is deep in overbought territory, the close sits just under the upper Bollinger Band at $8.06 with band width at 28.02%, and Mansfield relative strength — despite a 13.75-point improvement in a month — is still fractionally below zero at −1.40%, meaning Iress has clawed back ground on the S&P/ASX 200 without yet leading it.

Snapshot as of August 14, 2026

① Price & Moving Averages

The two-year chart is a story of one long slide and one sharp repair. Iress traded around the $10 mark in late 2024, ground steadily lower through 2025 with a broad shelf of trade in the high-$8s and $9s, broke down again early in 2026, and bottomed at the $5.64 low that anchors the 52-week range. Everything on the current chart is the recovery from that low — which is why the close at $7.91 is simultaneously 40.2% above the trough and 23.8% below the $10.38 high.

The 90-day window shows the shape more precisely: an April–May drift into the low, a long flat base through June, a slow grind higher in July, and then a near-vertical acceleration in the final three weeks. The moving-average stack is unambiguous — the close sits above a rising SMA5 at $7.76, which sits above the SMA20 at $7.07, which sits above the SMA60 at $6.47. That configuration was inverted for most of the two-year window, so this is a genuine regime change rather than a one-week wobble.

The counterweight is extension. Band width has expanded to 28.02% and the close is pressed against the upper Bollinger Band at $8.06, while the 20-day mean sits nearly a dollar below at $7.07 — the gap between price and its own mean is the widest on this chart. Two structural markers matter here. First, the two-year anchored VWAP at $7.83 (anchor February 24, 2025) has just been reclaimed, so the average cost of the past eighteen months of trade is now beneath the market for the first time in the recovery. Second, the Fibonacci grid drawn on the $6.32 (July 24) to $8.02 (August 13) up-swing puts the first support retest zone at $7.62 (23.6%) and $7.37 (38.2%), with the 50% and 61.8% levels at $7.17 and $6.97 marking where the swing structure itself would come into question.

② Volume

Friday traded 1,460,964 shares against a 20-day average of 915,814 — a Vol/Avg ratio of 1.60×. The 90-day panel shows why that matters: participation expanded on consecutive sessions into the August 13 high, with the heaviest bars of the past two months arriving on the final push rather than on the earlier base-building. Volume confirming price on the way up is the textbook version of a healthy advance, and this chart has it.

Two qualifications keep the reading honest. Friday's expanded turnover accompanied a close below Thursday's $8.02 high, so at least part of that participation was supply meeting the move rather than pure demand. And the single largest bar in the 90-day window sits back in late May, around the base — that was capitulation-style volume at the low, not part of the current leg.

Liquidity is not a constraint here. Roughly 0.9 million shares a day on average at a $7.91 share price puts Iress well clear of the thin-trading distortions that make volume and OBV unreliable in ASX small caps, so both panels on this page can be read closer to face value than is usual on this site.

③ MACD

MACD crossed above its signal line on July 27, 2026, and the separation has widened every week since: the line reads 0.374, the signal 0.283, and the histogram is positive at +0.091. Both the line and the histogram are at their highest levels of the 90-day window, and on the two-year panel the MACD line is at the top of its two-year range — momentum is not merely positive, it is unusually strong by this stock's own historical standard.

The cross itself formed just above the zero line after an extended period of sub-zero readings through the April–June base, which is the constructive variety: it marks the handover from repair to trend rather than a late-cycle re-acceleration. The honest caveat is that readings at the top of a two-year range are, by definition, hard to extend. The first warning would be a histogram that peaks and contracts over several sessions while price stalls beneath $8.02 — momentum fading ahead of price is the standard early tell.

④ RSI

RSI(14) reads 75.5 on the 90-day panel and 75.4 on the two-year — comfortably above the 70 overbought threshold, and the highest reading on the two-year chart. Importantly, no divergence is flagged on either timeframe: momentum has been making higher highs alongside price, which is confirmation rather than warning. This is the panel most likely to be misread by newer chart readers.

Overbought is a description of speed, not a verdict on direction. With ADX at 45, this is precisely the regime in which RSI can sit in the 70–80 band for weeks — strong trends routinely stay overbought, and calling a top purely because an oscillator is high is one of the most reliable ways to be early and wrong. What it does say is that the move is stretched relative to its own recent range, so the risk of a sharp mean-reverting session is elevated.

The reading that would change the picture is a divergence forming: a higher price high above $8.02 accompanied by an RSI peak below 75.5. Until that shape appears — and until price confirms it by breaking structure — an overbought RSI in a 45-ADX trend is a caution flag, not a reversal signal.

⑤ Mansfield Relative Strength

This is the most nuanced panel on the page. Mansfield RS versus the S&P/ASX 200 stands at −1.40% with a rising slope. A week ago it was −9.94 and a month ago −15.15, so the change is +8.55 week-over-week and +13.75 month-over-month — a very steep rate of improvement. Because the reading is still in negative territory, the correct label is improving, not accelerating: the line is travelling toward zero from below, and the distinction matters.

The common error here is to see a steeply rising RS line and call it leadership. It is not — not yet. A negative Mansfield reading means that over the measurement window Iress has still underperformed the index; what has changed is the direction of that gap, and the gap is now within a whisker of closing. The two-year panel frames it properly: RS was positive in late 2024, spent the whole of 2025 and the first half of 2026 below zero, reached roughly −28 at the worst of it, and has spent the past six weeks retracing that entire hole.

A cross above zero — which is only 1.40 points away — would be the single most consequential change available on this chart, because it turns a strong-looking absolute chart into a genuine relative-strength chart. A stall just beneath zero, on the other hand, would say the advance was a beta-driven catch-up rather than the start of outperformance.

⑥ ATR & ADX

ATR(14) is $0.223, or 2.8% of price — moderate in absolute terms, but the 90-day panel shows it turning sharply higher in the last few sessions as the advance steepened. This is the number that sizes the structural references on this page: the 1×ATR level sits at $7.69 and the 2×ATR technical invalidation level at $7.46, both measured from Friday's close. The invalidation level is 5.6% below the market, which is a relatively tight band — and it will widen if ATR keeps expanding.

ADX is the headline reading: 45.3 on the 90-day panel and 44.7 on the two-year, far above the 25 line that defines a strong trend. ADX measures strength, not direction, so this simply confirms that the move off the June base has been forceful and persistent rather than choppy. It is also worth noting that readings above 40 are historically the top decile for most charts, and that they usually resolve through a pause or consolidation rather than by climbing indefinitely — a high ADX describes what has happened, not what comes next.

⑦ OBV

Both timeframes read accumulation with a rising slope, but they describe different things. On the 90-day window OBV sits at 2.86M against a 20-day average of −935,360 — the cumulative line has flipped from negative to positive within the last few sessions, which is the cleanest flow signal on this page. The headline divergence figure of 405.52% above its MA20 should be treated with care: the denominator is a near-zero average, so the percentage is arithmetically inflated. The meaningful fact is the sign change, not the size of the number.

The two-year window is the sober counterpart. OBV there is at −19.89M against a −23.68M average, a +16.02% divergence — above its MA and rising, but the absolute line remains deeply negative. Years of net distribution built during the 2025 decline have not been repaired by six weeks of accumulation, and that is visible as a large gap between the current OBV level and where it stood at the start of the two-year window.

Read together: near-term flow confirms the advance, long-term flow does not yet corroborate a completed base. That is a reasonable state of affairs for a stock six weeks into a recovery, but it is the reason this chart is best described as an early-stage repair rather than a mature uptrend.

Scenarios

Key Levels & Volatility References

What to Watch

• A daily close above $8.02 on at least 1.5× average volume — the confirmation that turns a three-week thrust into a continuation.
• Whether Mansfield RS crosses above zero from −1.40% — the single most consequential change on this chart, since it converts a strong absolute trend into genuine outperformance versus the S&P/ASX 200.
• Behaviour on the first pullback into $7.83–$7.62 — a higher low against the two-year aVWAP and the 23.6% retracement keeps the up-swing structure intact; losing $6.97 (61.8%) breaks it.
• Whether an RSI divergence forms: a price high above $8.02 with a momentum peak below 75.5 would be the first genuine warning from this panel.
• Whether 90-day OBV keeps printing higher highs now that it has flipped positive, and whether the two-year line makes progress on its −19.89M deficit.

Conclusion

Past Analyses of This Stock same ticker · newest first

Other signals from this issue same publication date · 5 stocks

← All charts